3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets

Area of Science:

• Genomics
• Structural Biology
• Cancer Research

Background:

• Many cancer mutations lack clear functional significance, hindering targeted therapies.
• Current methods focus on common mutations, overlooking rare but potentially critical ones.

Purpose of the Study:

• To develop a novel method for identifying functionally significant rare mutations in cancer.
• To analyze spatial clustering of mutations in protein structures to uncover long-tail mutation impact.
• To experimentally validate identified potential driver mutations.

Main Methods:

• Analysis of mutation recurrence within spatially clustered residues in protein structures.
• Examination of 10,000 tumor exomes to identify rarely mutated residues.
• Experimental validation of candidate mutations in RAC1 and MAP2K1 genes.

Main Results:

• Identification of over 3000 rarely mutated residues with potential functional significance.
• Experimental validation of several identified potential driver mutations.
• Development of web resources (3dhotspots.org, cBioPortal.org) for accessing these findings.

Conclusions:

• Spatial clustering analysis effectively identifies functional rare cancer mutations.
• These findings expand the scope of genomic-driven clinical trials and personalized medicine.
• The identified mutations offer new targets for cancer therapy and clinical trial stratification.